The findings are based on interviews with leaders from the private sector and stakeholder groups, an assessment of more than 220 partnerships, a survey of pharmaceutical industry executives, and a multi-stakeholder roundtable convened in Geneva in December 2011. For this research, BSR also developed a uniform framework for companies to measure and report on impact. The framework assesses the impact of partnerships formed around four health challenge areas: availability of treatment, health system infrastructure, research and development, and awareness/prevention.

Download Report